These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 21090962)

  • 21. Acupuncture and regulation of gastrointestinal function.
    Li H; He T; Xu Q; Li Z; Liu Y; Li F; Yang BF; Liu CZ
    World J Gastroenterol; 2015 Jul; 21(27):8304-13. PubMed ID: 26217082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndrome.
    Katiraei P; Bultron G
    World J Gastroenterol; 2011 Jun; 17(23):2791-800. PubMed ID: 21734786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of experimental models in developing new treatments for irritable bowel syndrome.
    Holschneider DP; Bradesi S; Mayer EA
    Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):43-57. PubMed ID: 21309671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome.
    Salaga M; Binienda A; Tichkule RB; Thakur GA; Makriyannis A; Storr M; Fichna J
    Eur J Pharmacol; 2018 Oct; 836():34-43. PubMed ID: 30121173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional abdominal pain.
    Grover M; Drossman DA
    Curr Gastroenterol Rep; 2010 Oct; 12(5):391-8. PubMed ID: 20694840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent abdominal pain: an update.
    Boyle JT
    Pediatr Rev; 1997 Sep; 18(9):310-20; quiz 321. PubMed ID: 9286150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclic derivatives of morphiceptin possess anti-transit effect in the gastrointestinal tract and alleviate abdominal pain in mice.
    Szymaszkiewicz A; Włodarczyk J; Mazur M; Olczak J; Fichna J; Zielińska M
    Pharmacol Rep; 2020 Apr; 72(2):314-321. PubMed ID: 32125684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutrient drink test: A promising new tool for irritable bowel syndrome diagnosis.
    Estremera-Arevalo F; Barcelo M; Serrano B; Rey E
    World J Gastroenterol; 2019 Feb; 25(7):837-847. PubMed ID: 30809083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of the Gastrointestinal Microbiota in Visceral Pain.
    Rea K; O'Mahony SM; Dinan TG; Cryan JF
    Handb Exp Pharmacol; 2017; 239():269-287. PubMed ID: 28035535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease.
    Mayer EA; Tillisch K; Bradesi S
    Aliment Pharmacol Ther; 2006 Sep; 24(6):919-33. PubMed ID: 16948804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.
    Elsenbruch S
    Brain Behav Immun; 2011 Mar; 25(3):386-94. PubMed ID: 21094682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Psychobiological mechanisms in the pathophysiology of chronic visceral pain].
    Elsenbruch S; Enck P
    Schmerz; 2016 Oct; 30(5):407-411. PubMed ID: 27333768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome.
    Sagami Y; Shimada Y; Tayama J; Nomura T; Satake M; Endo Y; Shoji T; Karahashi K; Hongo M; Fukudo S
    Gut; 2004 Jul; 53(7):958-64. PubMed ID: 15194643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bugs on the brain; brain in the gut--seeking explanations for common gastrointestinal symptoms.
    Quigley EM
    Ir J Med Sci; 2013 Mar; 182(1):1-6. PubMed ID: 23179664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An observational study of headaches in children and adolescents with functional abdominal pain: Relationship to mucosal inflammation and gastrointestinal and somatic symptoms.
    Friesen C; Singh M; Singh V; Schurman JV
    Medicine (Baltimore); 2018 Jul; 97(30):e11395. PubMed ID: 30045261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Bioelectronics in the Gastrointestinal Tract.
    Miller L; Farajidavar A; Vegesna A
    Cold Spring Harb Perspect Med; 2019 Sep; 9(9):. PubMed ID: 30249600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neurobiology of irritable bowel syndrome.
    Mayer EA; Ryu HJ; Bhatt RR
    Mol Psychiatry; 2023 Apr; 28(4):1451-1465. PubMed ID: 36732586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: characterization of the action of palvanil in the mouse gastrointestinal tract.
    Szymaszkiewicz A; Włodarczyk J; Wasilewski A; Di Marzo V; Storr M; Fichna J; Zielińska M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Aug; 393(8):1357-1364. PubMed ID: 32002574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs acting on serotonin receptors for the treatment of functional GI disorders.
    Tonini M; Pace F
    Dig Dis; 2006; 24(1-2):59-69. PubMed ID: 16699264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irritable bowel syndrome, the microbiota and the gut-brain axis.
    Raskov H; Burcharth J; Pommergaard HC; Rosenberg J
    Gut Microbes; 2016 Sep; 7(5):365-83. PubMed ID: 27472486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.